Provention Bio, Inc. - stock earnings
Stock symbol PRVB is outdated, potentially delisted? Maybe it is available on other exchange?
PRVB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -33.3 million USD | ? USD |
| 2022Q3 | -28.6 million USD | 756000 USD |
| 2022Q2 | -29.7 million USD | 746000 USD |
| 2022Q1 | -22.0 million USD | 580000 USD |
| 2021Q4 | -25.8 million USD | 717000 USD |
| 2021Q3 | -27.0 million USD | 678000 USD |
| 2021Q2 | -29.1 million USD | ? USD |
| 2021Q1 | -32.4 million USD | ? USD |
| 2020Q4 | -32.6 million USD | ? USD |
| 2020Q3 | -31.3 million USD | ? USD |
PRVB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -113.6 million USD | 12.9 million USD |
| 2021 | -114.4 million USD | 1.4 million USD |
| 2020 | -98.6 million USD | ? USD |
| 2019 | -43.3 million USD | ? USD |
| 2018 | -26.5 million USD | ? USD |
| 2017 | -9.1 million USD | ? USD |
PRVB
Price: $24.98
52 week price:
Earnings Per Share: -0.13 USD
P/E Ratio: -9.92
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 631000
Market Capitalization: 2.3 billion